Hatice Duzkale

1.2k total citations
12 papers, 423 citations indexed

About

Hatice Duzkale is a scholar working on Molecular Biology, Genetics and Immunology. According to data from OpenAlex, Hatice Duzkale has authored 12 papers receiving a total of 423 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 5 papers in Genetics and 4 papers in Immunology. Recurrent topics in Hatice Duzkale's work include Retinoids in leukemia and cellular processes (3 papers), Acute Myeloid Leukemia Research (2 papers) and Genomics and Rare Diseases (2 papers). Hatice Duzkale is often cited by papers focused on Retinoids in leukemia and cellular processes (3 papers), Acute Myeloid Leukemia Research (2 papers) and Genomics and Rare Diseases (2 papers). Hatice Duzkale collaborates with scholars based in United States, Türkiye and Slovakia. Hatice Duzkale's co-authors include Heather M. McLaughlin, Matthew S. Lebo, Stephen P. Daiger, Robert R. German, Jun Shen, Catherine J. Spellicy, John R. Heckenlively, Trevor J. Pugh, Charles García and Hope Northrup and has published in prestigious journals such as Blood, Investigative Ophthalmology & Visual Science and Cancer Chemotherapy and Pharmacology.

In The Last Decade

Hatice Duzkale

12 papers receiving 421 citations

Peers

Countries citing papers authored by Hatice Duzkale

Since Specialization

Citations

This map shows the geographic impact of Hatice Duzkale's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hatice Duzkale with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hatice Duzkale more than expected).

Fields of papers citing papers by Hatice Duzkale

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hatice Duzkale. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hatice Duzkale. The network helps show where Hatice Duzkale may publish in the future.

Co-authorship network of co-authors of Hatice Duzkale

This figure shows the co-authorship network connecting the top 25 collaborators of Hatice Duzkale. A scholar is included among the top collaborators of Hatice Duzkale based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hatice Duzkale. Hatice Duzkale is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

12 of 12 papers shown

#	Work	Indexed citations
1	Reporting of Clinical Genome Sequencing Results 2018 ·Current Protocols in Human Genetics ·(unknown), Hatice Duzkale, Jun Shen	1
2	Clinical Application of Massively Parallel Sequencing in the Diagnosis of Hereditary Hemolytic and Dyserythropoietic Anemias 2016 ·Blood ·Harry Lesmana, Georgios E. Christakopoulos, Katie Seu, (unknown), Hatice Duzkale, Neha Dagaonkar, Kejian Zhang, Theodosia A. Kalfa	2
3	Deletion of chromosome 8q22.1, a critical region for Nablus mask‐like facial syndrome: Four additional cases support a role of genetic modifiers in the manifestation of the phenotype 2015 ·American Journal of Medical Genetics Part A ·Saumya Shekhar Jamuar, Hatice Duzkale, (unknown), Chengsheng Zhang, Frances A. High, Leonard B. Kaban, (unknown), Barbara F. Crandall, Sibel Kantarci, Joan M. Stoler, Angela E. Lin	6
4	Inherited CHST11/MIR3922 deletion is associated with a novel recessive syndrome presenting with skeletal malformation and malignant lymphoproliferative disease 2015 ·Molecular Genetics & Genomic Medicine ·(unknown), Ignaty Leshchiner, Hatice Duzkale, Heather M. McLaughlin, Monica A. Giovanni, Chengsheng Zhang, Nathan O. Stitziel, Joyce D. Fingeroth, Robin Joyce, Matthew S. Lebo, Heidi L. Rehm, Dana Vuzman, Richard L. Maas, Shamil Sunyaev, (unknown), Michael F. Murray, Christopher A. Cassa	9
5	A systematic approach to assessing the clinical significance of genetic variants 2013 ·Clinical Genetics ·Hatice Duzkale, Jun Shen, Heather M. McLaughlin, (unknown), (unknown), Trevor J. Pugh, (unknown), (unknown), Matthew S. Lebo	117
6	LDOC1 mRNA is differentially expressed in chronic lymphocytic leukemia and predicts overall survival in untreated patients 2011 ·Blood ·Hatice Duzkale, Carmen D. Schweighofer, Kevin R. Coombes, Lynn L. Barron, Alessandra Ferrajoli, Susan O’Brien, William G. Wierda, John D. Pfeifer, Tadeusz Majewski, Bogdan Czerniak, Jeffrey L. Jorgensen, L. Jeffrey Medeiros, Emil J. Freireich, Michael J. Keating, Lynne V. Abruzzo	26
7	104 LDOC1 mRNA Is Differentially Expressed in Chronic Lymphocytic Leukemia and Predicts Overall Survival in Untreated Patients 2011 ·Clinical Lymphoma Myeloma & Leukemia* ·Hatice Duzkale, Carmen D. Schweighofer, Kevin R. Coombes, Lynn L. Barron, Emil J. Freireich, Michael J. Keating, Lynne V. Abruzzo	1
8	MER1, a novel organic arsenic derivative, has potent PML-RARα- independent cytotoxic activity against leukemia cells 2009 ·Investigational New Drugs ·Mirna Golemović, Alfonso Quintás‐Cardama, Taghi Manshouri, Nada Oršolić, Hatice Duzkale, Mary Johansen, Emil J. Freireich, Hagop M. Kantarjian, Ralph A. Zingaro, Srđan Verstovšek	13
9	Prevalence of Disease-Causing Mutations in Families with Autosomal Dominant Retinitis Pigmentosa: A Screen of Known Genes in 200 Families 2006 ·Investigative Ophthalmology & Visual Science ·Lori S. Sullivan, Sara J. Bowne, David G. Birch, Dianna K. Hughbanks-Wheaton, John R. Heckenlively, Richard A. Lewis, Charles García, Robert R. German, Susan H. Blanton, Hope Northrup, Anisa Gire, (unknown), Hatice Duzkale, Catherine J. Spellicy, Jingya Zhu, Suma P. Shankar, Stephen P. Daiger	220
10	Bone marrow purging studies in acute myelogenous leukemia using the recombinant anti-CD33 immunotoxin HuM195/rGel 2003 ·Biology of Blood and Marrow Transplantation ·Hatice Duzkale, Lance C. Pagliaro, Michael G. Rosenblum, Ali Varan, (unknown), James M. Reuben, William G. Wierda, Martin Körbling, John D. McMannis, Armand B. Glassman, David A. Scheinberg, Emil J. Freireich	10
11	In vitro activity of dimethylarsinic acid against human leukemia and multiple myeloma cell lines 2003 ·Cancer Chemotherapy and Pharmacology ·Hatice Duzkale, Iman Jilani, Nada Oršolić, Ralph A. Zingaro, Mirna Golemović, Francis J. Giles, Hagop Kantarjian, Maher Albitar, Emil J. Freireich, Srđan Verstovšek	16
12	Development of an organic arsenic derivative as a therapy for leukaemia 2003 ·Mirna Golemović, Hagop Kantarjian, Nada Oršolić, Ralph A. Zingaro, (unknown), Cheng Zhang, Mary Johansen, Hatice Duzkale, Peggy T. Tinkey, Tony Lembo, Carolyn Van Pelt, (unknown), Francis J. Giles, Jörge E. Cortes, EJ Freireich, Srđan Verstovšek	2

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact